Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangjing Qiyuan Gao is a Traditional Chinese Medicine (TCM) formulation developed by the Sichuan College of Traditional Chinese Medicine. It is primarily indicated for the treatment of Yin deficiency, a condition in TCM characterized by symptoms such as fatigue, dizziness, and weakness. The preparation is a "Gao" (medicinal paste or electuary) composed of key herbal ingredients including *Polygonatum sibiricum* (Huangjing), *Lycium barbarum* (Gouqizi), and *Dimocarpus longan* (Guiyuan). These components work synergistically to nourish the Yin of the lungs, spleen, and kidneys, replenish vital essence, and improve overall vitality. The formulation is typically used as a tonifying agent to restore balance in patients suffering from chronic depletion or age-related decline.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huangjing qiyuan gao.